Picture of InMode logo

INMD — InMode News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedMid CapSuper Stock

InMode Ltd Q3 revenue beats estimates

Overview

InMode Q3 2025 revenue of $93.2 mln beats analyst expectations

Net income for Q3 2025 misses analyst estimates

Outlook

InMode maintains full-year 2025 revenue guidance between $365 mln and $375 mln

Non-GAAP EPS for 2025 expected between $1.55 and $1.59

Company continues to monitor geopolitical developments in Israel

Result Drivers

REVENUE DECLINE - Q3 revenue decreased due to absence of pre-order sales from previous year

CONSUMABLES GROWTH - Revenue from consumables and services increased by 26% year-over-year

U.S. SALES IMPACT - Lower U.S. sales affected operating margins, the company's most profitable region

Key Details

MetricBeat/MissActualConsensus Estimate
Q3 RevenueBeat$93.17 mln$88.34 mln (7 Analysts)
Q3 Net IncomeMiss$21.86 mln$22.67 mln (5 Analysts)
Q3 Gross Margin78%
Q3 Pretax ProfitBeat$25.61 mln$24.98 mln (6 Analysts)
Q3 Operating Expenses$51.41 mln
Analyst Coverage The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 1 "strong buy" or "buy", 6 "hold" and no "sell" or "strong sell" The average consensus recommendation for the advanced medical equipment & technology peer group is "buy." Wall Street's median 12-month price target for Inmode Ltd is $16.00, about 8.6% above its November 4 closing price of $14.63 The stock recently traded at 9 times the next 12-month earnings vs. a P/E of 8 three months ago Press Release: ID:nPn6WqHSJa For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com. (This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Recent news on InMode

See all news